Cargando…
Neoadjuvant immunotherapy for colorectal cancer: Right regimens, right patients, right directions?
Neoadjuvant chemoradiotherapy (NACRT) or chemotherapy (NACT) followed by radical resection and then adjuvant therapy is considered the optimal treatment model for locally advanced colorectal cancer (LACRC). A recent total neoadjuvant therapy (TNT) strategy further improved the tumour regression rate...
Autores principales: | Zhu, Jiahao, Lian, Jie, Xu, Benjie, Pang, Xiangyi, Ji, Shengjun, Zhao, Yutian, Lu, Haibo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026962/ https://www.ncbi.nlm.nih.gov/pubmed/36949951 http://dx.doi.org/10.3389/fimmu.2023.1120684 |
Ejemplares similares
-
Neoadjuvant immunotherapy for non-small cell lung cancer: right drugs, right patient, right time?
por: Ahern, Elizabeth, et al.
Publicado: (2021) -
Role of endogenous and exogenous antioxidants in risk of six cancers: evidence from the Mendelian randomization study
por: Zhu, Jiahao, et al.
Publicado: (2023) -
Intrinsic resistance and efficacy of immunotherapy in microsatellite instability-high colorectal cancer: A systematic review and meta-analysis
por: Wang, Ren, et al.
Publicado: (2023) -
The challenge of making the right choice: patient avatars in the era of cancer immunotherapies
por: Kayser, Charlotte, et al.
Publicado: (2023) -
Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time
por: van Willigen, Wouter W., et al.
Publicado: (2018)